PharmiWeb

Newron presents H1 2025 results and provides business update

Milan, Italy, September 16, 2025, 07:00 am CEST – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for ...
Business Wire

Newron TRS Study 6 Months’ Results: Evenamide Substantially Improves Patients to an Extent That They No Longer Meet Protocol Entry Criteria

MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the ...
Business Wire

Newron Announces 2021 Financial Results and Provides Outlook for 2022 | Business Wire

MILAN-- (BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the ...
VentureBeat

Newron Pharmaceuticals Announces Planned Pivotal Trial Design for Sarizotan for Patients with Rett Syndrome, a Rare Neurodevelopmental Disease

Recognizes Rett Syndrome Awareness Month* Provides update on early-stage pipeline prioritization Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel central ...
Yahoo Finance

Newron Announces AGM 2026 Results

MILAN, ITALY - April 23, 2026 (NEWMEDIAWIRE) - Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients ...
PharmiWeb

Newron extends Senior Management team and strengthens commitment to ESG

Milan, Italy, July 1, 2022 – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of ...
Yahoo Finance

Newron Announces Agreement With the European Investment Bank (EIB) to Extend the Near-Term Tranche Repayment Dates of Its 2018 Finance Contract

MILAN & MORRISTOWN, N.J., March 19, 2026--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies ...
VentureBeat

Newron Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases

Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today ...